Synopsis: Jefferies maintains a Buy rating on Axis Bank with a target price of ₹1,700, citing strong deposit growth, improving asset quality, and healthy lending momentum. This Private Sector Bank Stock, engaged in providing retail, corporate, and investment banking...
Synopsis: Citi maintained a Buy rating on Kalyan Jewellers with a ₹750 target price, implying an 111.33% upside, supported by strong expansion, Candere’s growth, and long-term prospects. This Mid-Cap Jewellery Stock, engaged in the retail and sale of gold,...
Synopsis: Shares of KPIT Technologies are in focus after Goldman Sachs cut its target price by 16% and trimmed earnings estimates, citing weaker client spending and slower automotive R&D investments, raising concerns over the company’s near-term growth...
Synopsis: Antique initiated coverage on Clean Max Enviro Energy Solutions Limited with a Buy rating, citing strong renewable energy growth, long-term contracts, and a 35.52% upside potential. This Small-cap stock, engaged in developing, owning, and operating renewable...
Synopsis: Investec maintains an Accumulate rating on Crompton Greaves Consumer Electricals with a ₹410 target, implying 51% upside. Growth is driven by strong revenue visibility, market share gains, expansion in the solar and wires businesses, new category entry, and...
Synopsis: A small-cap real estate developer with deep pockets and a growing land bank has caught a leading brokerage’s eye, with analysts betting on a sharp re-rating as newer projects start contributing to growth. While much of the investor attention in real...
Synopsis: Leading brokerages have issued fresh “Buy” ratings on five stocks across specialty chemicals, insurance, steel tubes, IT, and infrastructure consultancy sectors, citing strong fundamentals and growth prospects. With upside potential ranging...
Synopsis: A leading brokerage believes defence manufacturing in India is entering a new phase, where established players are quietly building revenue streams far beyond what made them famous. Three names are drawing particular attention as this shift unfolds....
Synopsis: Nomura has recommended Niva Bupa and Star Health as Buy, with upside potential of up to 23%, while maintaining a Neutral rating on ICICI Lombard. Nomura has initiated coverage on leading insurance companies, sharing its outlook on their future growth,...
